Lyell Immunopharma (LYEL) Non Operating Income (2021 - 2026)
Lyell Immunopharma's Non Operating Income was $2.58 million in Q2 2026, down 42.1% from $4.46 million a year earlier and down 87.2% from the prior quarter.
Powered by 
Analysis
Lyell Immunopharma (LYEL) Non Operating Income (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Lyell Immunopharma's Non Operating Income was $8.02 million through Jun 30, 2026, down 67.6% year-over-year; for FY2025, it was -$5.04 million.
- In earlier years, Non Operating Income was $15.76 million in FY2024 (+27.4%), $12.38 million in FY2023 (+214.1%), $3.94 million in FY2022 and -$35.44 million in FY2021.
- Quarterly Non Operating Income has moved between -$36.17 million (Q4 2021) and $20.11 million (Q1 2026) over five years.
- Compared with a year earlier, Non Operating Income was higher in two of the last five quarters, with growth averaging 47.4%.
- The best year-over-year quarter for Non Operating Income over five years was Q2 2022 (growth of 737.5%); the worst was Q2 2026 (a decline of 42.1%).
- Per Business Quant data, LYEL's Non Operating Income in the three quarters before Q2 2026 was $20.11 million (Q1 2026), -$13.08 million (Q4 2025) and -$1.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Lyell Immunopharma | 229.06 Mn | 229.06 Mn | - | 2.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.58 Mn |
| Mar 31, 2026 | 20.11 Mn |
| Dec 31, 2025 | -13.08 Mn |
| Sep 30, 2025 | -1.59 Mn |
| Jun 30, 2025 | 4.46 Mn |
| Mar 31, 2025 | 5.17 Mn |
| Dec 31, 2024 | 9.21 Mn |
| Sep 30, 2024 | 5.92 Mn |
| Jun 30, 2024 | 5.72 Mn |
| Mar 31, 2024 | -5.09 Mn |
| Dec 31, 2023 | 6.58 Mn |
| Sep 30, 2023 | 8.19 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Mar 31, 2023 | -4.40 Mn |
| Dec 31, 2022 | 6.39 Mn |
| Sep 30, 2022 | -3.82 Mn |
| Jun 30, 2022 | 938,000.00 |
| Mar 31, 2022 | 432,000.00 |
| Dec 31, 2021 | -36.17 Mn |
| Sep 30, 2021 | 286,000.00 |
API Access
Lyell Immunopharma Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();